Anadolu Medical Center
| トルコ | オーストリア | スペイン | |
| 血漿交換術 | から $1,200 | から $2,000 | から $1,800 |
| 血漿交換 | から $3,900 | - | - |
| 治療的アフェレーシス | から $1,350 | - | - |
| カスケードプラズマろ過 | から $1,850 | - | - |
ザフェル・ギュルバシュ教授はアナドル医療センターにおける骨髄移植センターを設立し、トルコを代表する血液腫瘍専門医です。
ビュレント・カラゴズ博士は、腫瘍生物学と免疫療法を専門とする、33年の経験以上の経験を持つトルコのトップ腫瘍内科医です。
Dr. Omur Gokmen Sevindik is a hematologist at Istanbul Florence Nightingale Hospital. He completed a fellowship at the Mayo Clinic, a top-ranked medical center in the US. Dr. Sevindik specializes in treating blood cancers like leukemia and lymphoma. He works at a JCI-accredited facility that treats 300,000 patients annually.
Turkey is a leading myeloma treatment hub offering JCI-accredited care and advanced hematology units. Facilities like Anadolu Medical Center provide autologous stem cell transplantation and modern drug therapies. Patients access specialized centers with high success rates and no waiting lists for urgent blood disorder treatments.
Bookimed Expert Insight: Turkish hematology centers demonstrate exceptional depth in bone marrow transplantation. Dr. Zafer Gulbas at Anadolu Medical Center reports an 81% success rate for autologous transplants. This high performance likely stems from performing over 3,300 specialized procedures. Patients benefit from this concentrated surgical expertise often found in top-tier Istanbul hospitals.
Patient Consensus: Patients emphasize the high efficiency of medical staff and the quality of care. They note that the coordination between doctors and international departments makes the treatment process smooth.
Turkish clinics offer advanced hematology-oncology treatments including bone marrow transplants, targeted therapies, and immunotherapy. JCI-accredited centers like Anadolu Medical Center and Memorial Health Group utilize multidisciplinary teams for myeloma. Specialized care involves academic protocols developed in partnership with institutions like Johns Hopkins Medicine.
Bookimed Expert Insight: While many clinics offer general oncology, Turkish centers with higher patient volumes, like Anadolu Medical Center or Medipol Mega, provide concentrated expertise in blood disorders. Prof. Dr. Zafer Gulbas at Anadolu has managed over 3,300 transplant procedures. Choosing a hospital based on specific hematology-oncology department size rather than general clinic fame often leads to better coordinated care.
Patient Consensus: Patients value the speed of appointment scheduling and the presence of dedicated international coordinators. They emphasize that bone marrow transplant infrastructure and English-speaking medical staff are critical factors for long-term treatment success.
Leading Turkish hospitals for myeloma treatment include Anadolu Medical Center, Memorial Şişli, and Medipol Mega University Hospital. These JCI-accredited centers specialize in autologous bone marrow transplants. They offer advanced diagnostics like sentinel lymph node biopsy and oncohematology consultations. Expert teams manage complex cases using international protocols.
Bookimed Expert Insight: Anadolu Medical Center stands out for myeloma care because of its 81% success rate in autologous transplants. High-volume centers like Medipol serve 1,000,000 patients yearly. This scale often reflects deeper experience in managing rare hematological complications than smaller clinics. We recommend prioritizing hospitals like Anadolu or Medipol that house dedicated bone marrow transplant units in-house.
Patient Consensus: Patients emphasize the value of having a full hematology team and suggest checking for English-speaking coordinators before traveling. They note that the quality of staff and doctors at centers like Anadolu and Medipol makes for an excellent experience.
Myeloma treatment in Turkey involves a multi-stage protocol. Intensive phases like stem cell transplants require a hospital stay of 3 to 4 weeks. Outpatient care, such as drug therapy or initial scans, allows for quicker returns. Patients usually spend several weeks in-country to monitor recovery and blood counts.
Bookimed Expert Insight: Anadolu Medical Center performs over 3,000 transplants with an 81% success rate. High-volume centers like this provide multidisciplinary tumor boards. These boards review complex cases to shorten the diagnostic phase. Choosing experienced teams helps streamline the transition from intensive care to outpatient recovery.
Patient Consensus: Patients emphasize the need for extra days in Turkey after finishing treatment. Travel is often difficult immediately after intensive therapy due to low blood counts and weakness.